Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M80,367Revenue (TTM) $M17,093Net Margin (%)83.9Altman Z-Score1.4
Enterprise Value $M90,679EPS (TTM) $35.4Operating Margin %-8.0Piotroski F-Score7
P/E(ttm)6.1Beneish M-Score-1.9Pre-tax Margin (%)-14.6Higher ROA y-yY
Price/Book1.010-y EBITDA Growth Rate %--Quick Ratio3.9Cash flow > EarningsN
Price/Sales4.85-y EBITDA Growth Rate %-8.2Current Ratio4.0Lower Leverage y-yY
Price/Free Cash Flow30.9y-y EBITDA Growth Rate %286ROA % (ttm)10.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)17.7Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M375ROIC % (ttm)-0.8Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNKen Fisher 2016-12-31 Add$188.47 - $242.65
($207.16)
$ 214.343%Add 0.60%4,048
AGNCarl Icahn 2016-09-30 Reduce-3.39%$230.31 - $260.24
($244.37)
$ 214.34-12%Reduce -87.49%425,438
AGNLeon Cooperman 2016-09-30 Reduce-0.85%$230.31 - $260.24
($244.37)
$ 214.34-12%Reduce -19.38%541,122
AGNDavid Tepper 2016-09-30 Reduce-0.26%$230.31 - $260.24
($244.37)
$ 214.34-12%Reduce -3.37%1,218,309
AGNJohn Paulson 2016-09-30 Reduce-0.14%$230.31 - $260.24
($244.37)
$ 214.34-12%Reduce -1.45%3,891,134
AGNWallace Weitz 2016-09-30 Add0.12%$230.31 - $260.24
($244.37)
$ 214.34-12%Add 2.35%609,963
AGNPrivate Capital 2016-09-30 Reduce-0.09%$230.31 - $260.24
($244.37)
$ 214.34-12%Reduce -1.93%134,667
AGNVanguard Health Care Fund 2016-09-30 Reduce-0.07%$230.31 - $260.24
($244.37)
$ 214.34-12%Reduce -1.23%11,917,739
AGNJoel Greenblatt 2016-09-30 Sold Out -0.06%$230.31 - $260.24
($244.37)
$ 214.34-12%Sold Out0
AGNTom Gayner 2016-09-30 Buy 0.01%$230.31 - $260.24
($244.37)
$ 214.34-12%New holding2,000
AGNMario Gabelli 2016-09-30 Reduce-0.01%$230.31 - $260.24
($244.37)
$ 214.34-12%Reduce -8.09%55,988
AGNRuane Cunniff 2016-09-30 Reduce$230.31 - $260.24
($244.37)
$ 214.34-12%Reduce -10.48%3,075
AGNKen Fisher 2016-09-30 Add$230.31 - $260.24
($244.37)
$ 214.34-12%Add 11.96%4,024
AGNRon Baron 2016-09-30 Add$230.31 - $260.24
($244.37)
$ 214.34-12%Add 22.88%17,109
AGNDavid Tepper 2016-06-30 Add5.96%$201.65 - $277.55
($231.14)
$ 214.34-7%Add 351.73%1,260,809
AGNCarl Icahn 2016-06-30 Buy 3.88%$201.65 - $277.55
($231.14)
$ 214.34-7%New holding3,400,000
AGNJohn Paulson 2016-06-30 Reduce-2.98%$201.65 - $277.55
($231.14)
$ 214.34-7%Reduce -27.13%3,948,451
AGNWallace Weitz 2016-06-30 Add2.53%$201.65 - $277.55
($231.14)
$ 214.34-7%Add 95.58%595,961
AGNSteve Mandel 2016-06-30 Sold Out -2.39%$201.65 - $277.55
($231.14)
$ 214.34-7%Sold Out0
AGNRuane Cunniff 2016-06-30 Reduce-2.13%$201.65 - $277.55
($231.14)
$ 214.34-7%Reduce -99.67%3,435
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Basgoz NesliDirector 2016-12-08Sell500$188.7213.58view
SAUNDERS BRENT LCEO and President 2016-11-21Buy5,250$189.1313.33view
Hilado Maria TeresaCFO 2016-11-11Buy1,422$210.641.76view
Basgoz NesliDirector 2016-08-05Sell758$253.02-15.29view
Hilado Maria TeresaCFO 2016-06-02Buy661$241.57-11.27view
Basgoz NesliDirector 2016-05-11Sell459$225.1-4.78view
Basgoz NesliDirector 2015-12-07Sell2,300$312.96-31.51view
BISARO PAULExec Chairman 2015-08-24Buy1,000$297.42-27.93view
SAUNDERS BRENT LCEO and President 2015-08-21Buy1,000$301.94-29.01view
Basgoz NesliDirector 2015-06-09Sell2,200$297.89-28.05view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

News about AGN:

Articles On GuruFocus.com
Teva Is a Hold Nov 30 2016 
Weekly CEO Buys Highlight Nov 29 2016 
Weekly Top Insider Buys Highlight for Week of Nov. 18 Nov 19 2016 
John Griffin Expands Portfolio in 3rd Quarter Nov 16 2016 
Weitz Funds Comments on Allergan Nov 11 2016 
Weitz Balanced Fund 3rd Quarter Commentary Nov 11 2016 
3 Health Industry Sectors Bound to Profit From a Trump Presidency Nov 11 2016 
Markel’s Tom Gayner Buys 4 Stocks During Quarter Nov 08 2016 
Buy Health Care Now? It All Depends on the Election Nov 07 2016 
Allergan: Trading at a Low Earnings Multiple Nov 06 2016 

More From Other Websites
Novartis (NVS) Q4 Earnings: Stock Likely to Disappoint? Jan 20 2017
Jim Cramer Is No Fan of Retail Stocks in the Age of Amazon Jan 20 2017
Synergy Pharmaceuticals Secures Approval for Linzess Competitor Jan 20 2017
Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S. Jan 20 2017
Bull-Bear Battle Coming to a Head for Allergan Jan 19 2017
Should Value Investors Choose Allergan (AGN)? Jan 19 2017
Allergan says the FDA has approved its cream for facial redness Jan 19 2017
Allergan Announces FDA Approval Of RHOFADE™ (Oxymetazoline Hydrochloride) Cream, 1% For The... Jan 19 2017
Dealpolitik: SEC Tilts Playing Field Against Targets of Hostile Bids Jan 18 2017
Allergan's Uterine Fibroids Candidate Positive in Phase III Jan 18 2017
Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions Jan 18 2017
PRESS DIGEST- Wall Street Journal - Jan 18 Jan 18 2017
[$$] Allergan Admits to Disclosure Violations During Valeant Bid Jan 17 2017
AGN Falls Despite Positive Trial Results Jan 17 2017
Allergan and Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg... Jan 17 2017
Allergan, Schlumberger, IBM: Doug Kass' Views Jan 16 2017
Jobless Claims and Trimming GLD: Best of Kass Jan 14 2017
Pharma company executives debate drug pricing increases Jan 12 2017
Lawsuit accuses Shire of monopolizing market for ADHD drug Jan 12 2017
Allergan to Report Fourth Quarter and Full Year 2016 Earnings and Host Conference Call and Webcast Jan 12 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)